Streetbeat News

Stock Prices

PVH

PVH Corp's stock is experiencing heightened volatility after the company released its third-quarter financial results and guidance for the full fiscal year 2023.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 4:47 pm

EIS

Israel and Hamas agreed to extend their ceasefire for an additional day, now totaling seven days. The extension came after intense mediation, with Israel requiring the release of at least 10 hostages daily. Ten hostages, including two with Russian citizenship, are set to be released. U.S. Secretary of State Antony Blinken is in the region, supporting the truce and humanitarian efforts. However, a Hamas attack in Jerusalem breached the ceasefire, killing three and injuring eight. Israeli stocks, tracked by iShares MSCI Israel ETF (EIS), dropped by 2%, and the shekel weakened against the dollar.

Portfolio Pulse from Piero Cingari

November 30, 2023 | 4:47 pm

CBRL

Cracker Barrel Old Country Store Inc (NASDAQ:CBRL) reported Q1 FY24 revenues of $823.8 million, a 1.9% decrease year-over-year, missing consensus estimates. Comparable store restaurant sales slightly decreased, while retail sales fell 8.1%. Adjusted operating income and EPS both declined, with EPS missing consensus estimates. The company provided FY24 revenue guidance that aligns with consensus and plans to open new stores. CBRL shares fell 5.47% following the report.

Portfolio Pulse from Vandana Singh

November 30, 2023 | 4:46 pm

RWBYF

Red White & Bloom Brands Inc. (RWBYF), a Canadian MSO, reported increased Q3 2023 revenue of CA$20.1 million and a net loss decrease to CA$6.5 million. Adjusted EBITDA rose to CA$1.6 million. The company reduced expenses and expanded into Ohio, with a focus on high-margin products and the upcoming Aleafia acquisition. RWBYF's stock surged 70.25% to $0.0475 per share.

Portfolio Pulse from Patricio Liddle

November 30, 2023 | 4:43 pm

CRM

BMO Capital analyst Keith Bachman has maintained an Outperform rating on Salesforce (NYSE:CRM) and increased the price target from $252 to $277, indicating a positive outlook on the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 4:42 pm

SLNH

Shares of Soluna Holdings were halted due to a circuit breaker after spiking 8.46% to the upside.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 4:37 pm

ZVSA

ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) has announced a 1-for-35 reverse stock split and an increase in authorized shares from 110M to 250M, effective December 4, 2023. This move aims to comply with Nasdaq's $1.00 minimum bid price requirement for continued listing. Adjustments will be made to equity awards, convertible securities, and warrants. No fractional shares will be issued, and stockholders need not take action as adjustments will be automatic.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 4:31 pm

GS

Options trading analysis for Goldman Sachs Group (NYSE:GS) shows a bullish sentiment with 58% of traders leaning bullish and 42% bearish. Unusual trading activity includes 17 trades, with 14 calls valued at $653,273 and 3 puts at $93,235. The focus is on a price range of $300 to $380 over the last three months. The largest options spotted were all calls, with varying sentiments and expiration dates. Goldman Sachs, a global investment banking and asset management firm, saw its stock price increase by 1.04% to $343.79. An analyst from Oppenheimer maintains an Outperform rating with a target price of $468.

Portfolio Pulse from Benzinga Insights

November 30, 2023 | 4:31 pm

ABBV

IMGN

AbbVie Inc (NYSE:ABBV) is set to acquire ImmunoGen Inc (NASDAQ:IMGN) for approximately $10.1 billion, gaining access to ImmunoGen's flagship cancer therapy Elahere. The transaction, approved by both boards, is expected to close in mid-2024 and be accretive to AbbVie's EPS starting in 2027. ImmunoGen's Q3 sales for Elahere were $105.2 million. ABBV shares rose 2.18%, while IMGN shares surged 81.7%.

Portfolio Pulse from Vandana Singh

November 30, 2023 | 4:30 pm

DIS

The Walt Disney Company (NYSE:DIS) responded to Nelson Peltz's statement regarding its Board of Directors. Disney highlighted its restructuring efforts, cost savings of $7.5 billion, and strategic focus on streaming profitability, ESPN's digital platform, film studio economics, and growth in Experiences. Disney expects free cash flow to near pre-COVID levels by fiscal 2024. The company also announced the appointment of new board members and the non-reelection of Francis A. deSouza. Peltz, with Isaac Perlmutter's backing, plans to present his case to shareholders. Disney will recommend its director nominees in an upcoming proxy statement.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 4:26 pm